Lowey Dannenberg P.C. is investigating Alignment Healthcare, Inc. for potential violations of federal securities laws. The investigation follows a July 8, 2026 whistleblower lawsuit filed by a former executive alleging the company misclassified $8 million to $10 million in routine operating expenses as capital expenditures to artificially inflate adjusted EBITDA. Following the news, Alignment stock fell $4.02 per share, or approximately 16.7%, to close at $20.03 per share. The law firm is examining whether the company and its executives provided accurate and complete information to investors.
Alignment Healthcare LLCWhistleblower lawsuit alleges misclassification of operating expenses as capital expenditures to inflate adjusted EBITDA, leading to a 16.7% stock drop.